On Oct. 26, 2026, Merck announced the first results from the pivotal Phase 3 TroFuse-005 trial evaluating sacituzumab…
On Oct. 20, 2026, GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen)…
On Oct. 16, 2026, Viatris announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine…
On Oct. 15, 2026, the Food and Drug Administration (FDA) this week submitted a peptide “interim access policy”…
On Oct. 9, 2026, the U.S. Food and Drug Administration (FDA) has approved Asahi Kasei Therapeutics’ Hovilpri (pritelivir)…
On Oct. 1, 2026, the U.S. Food and Drug Administration (FDA) approved Edwards Lifesciences’s Autus Size-Adjustable Valve, a…
On Sept. 25, 2026, the US Food and Drug Administration announced approval of AbbVie’s treatment for Parkinson’s disease…
On Sept. 24, 2026, Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin…
On Sept. 23, 2026, SystImmune announces the U.S. Food and Drug Administration (FDA) has cleared its Investigational New…
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
On Sept. 18, 2026, Eli Lilly and Company announced that the U.S. Food and Drug Administration(FDA) has granted…
On Sept. 17, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted standard full…
On Sept. 17, 2026, Bayer announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to…
On Sept. 16, 2026, The Lost Funds Project, a comprehensive resource tracking federal funding disruptions and their impacts…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 14, 2026, Paradromics, a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore…
On Sept. 14, 2026, Telix today announces that the U.S. Food and Drug Administration (FDA) has approved its…
On Sept. 8, 2026, Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for the…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Sept. 3, 2026, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™…
On Aug. 27, 2026, Roivant announced that the U.S. Food and Drug Administration (FDA) has approved LISRAYA™ (brepocitinib)…
On Aug. 27, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) approved Bixlenvo™ (bictegravir…
On Aug. 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for…
On Aug. 24, 2026, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY®…
On Aug. 24, 2026, Roche announced that the U.S. Food and Drug Administration (FDA) has cleared the Elecsys®…
On Aug. 19, 2026, the U.S. Food and Drug Administration (FDA) announced it has authorized the Aletta, the…
On Aug. 13, 2026, the U.S. Food and Drug Administration (FDA) has confirmed the findings of previous studies…
On Aug. 6, 2026, the Food and Drug Administration announced it has approved a new kind of flu…
On Aug. 5, 2026, Takeda announced that the U.S. Food and Drug Administration (FDA) had approved ORZEYFUL™ (oveporexton),…
On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…